🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06566898
Recruiting Observational

Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients

NCT06566898 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai General Hospital, China
Phase
Observational
Started
2024-08-01
Last updated
2026-04-23

Condition(s) studied

PneumoniaNext-generation SequencingMicrobiomeAntimicrobial Resistance

Study summary

Monitoring of antimicrobial resistance (AMR) based on metagenomics analyses in pneumonia patients is critical for optimizing clinical diagnosis and treatment and improving clinical prognosis. This study is designed to ask the following key questions:

1. What is the microbiome maps of patients with severe pneumonia and mild pneumonia ?
2. How many pathogen resistance genes are carrying in severe pneumonia and mild pneumonia ?
3. What is the genetic diversity of key pathogens detected in severe pneumonia and mild pneumonia during 2019-2025?

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Inclusion Criteria: * Patients clinically diagnosed as severe pneumonia and mild pneumonia are diagnosed according to the Guidelines for the diagnosis and Treatment of community-acquired pneumonia in Adults (2019 edition) formulated by the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA), who meet 1 of the following major criteria or ≥3 minor criteria can be diagnosed. The diagnostic criteria for severe and mild pneumonia in children were adopted by the British Thoracic Society (BTS) in 2011. * Clinical examination was performed, and there was biospecimen (nasopharyngeal swab, oropharyngeal swab, bronchoalveolar lavage fluid, sputum, blood, hydrothorax, lung tissue) remaining in the clinical microbiological examination. Exclusion Criteria: * Patients whose biological samples may be contaminated; * Patients with alveolar lavage fluid or hydrothorax volume less than 200μl.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Mei Kang Shanghai Shanghai Municipality Recruiting

More Shanghai General Hospital, China trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06566898 on ClinicalTrials.gov ↗ ← All trials in China